{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:22:17Z","timestamp":1778800937232,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1006\/bbrc.2001.5157","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T13:50:03Z","timestamp":1032184203000},"page":"201-206","source":"Crossref","is-referenced-by-count":17,"title":["Efficient Accommodation of Recombinant, Foot-and-Mouth Disease Virus RGD Peptides to Cell-Surface Integrins"],"prefix":"10.1006","volume":"285","author":[{"given":"Pilar","family":"Alcal\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi X.","family":"Feliu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ar\u0131\u00eds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Villaverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/bbrc.2001.5157_RF1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0167-7799(97)01137-2","article-title":"Viral vectors for gene therapy","volume":"16","author":"Robbins","year":"1998","journal-title":"Trends Biotechnol."},{"key":"10.1006\/bbrc.2001.5157_RF2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0167-7799(99)01416-X","article-title":"Gene therapy: The first decade","volume":"18","author":"Mountain","year":"2000","journal-title":"Trends Biotechnol."},{"key":"10.1006\/bbrc.2001.5157_RF3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/07853899809002481","article-title":"Vector development: A major obstacle in human gene therapy","volume":"30","author":"Jane","year":"1998","journal-title":"Ann. Med."},{"key":"10.1006\/bbrc.2001.5157_RF4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/45321","article-title":"Tighter watch urged on adenoviral vectors with proposal to report all adverse events","volume":"402","author":"Smaglik","year":"1999","journal-title":"Nature"},{"key":"10.1006\/bbrc.2001.5157_RF5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1089\/hum.1997.8.10-1253","article-title":"Gene transfer using a novel fusion protein, GAL4\/invasin","volume":"8","author":"Paul","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/bbrc.2001.5157_RF6","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1074\/jbc.271.18.10560","article-title":"Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system","volume":"271","author":"Fominaya","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1006\/bbrc.2001.5157_RF7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/(SICI)1097-0290(20000620)68:6<689::AID-BIT13>3.0.CO;2-A","article-title":"Exploiting viral cell-targeting abilities in a single polypeptide, non-infectious, recombinant vehicle for integrin-mediated DNA delivery and gene expression","volume":"68","author":"Ar\u0131&#x0301;s","year":"2000","journal-title":"Biotechnol. Bioeng."},{"key":"10.1006\/bbrc.2001.5157_RF8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nbt0895-801","article-title":"Improved mimicry of foot-and-mouth disease virus antigenic site by a viral peptide displayed on \u03b2-galactosidase surface","volume":"13","author":"Benito","year":"1995","journal-title":"BioTechnology"},{"key":"10.1006\/bbrc.2001.5157_RF9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-5793(98)00943-0","article-title":"Engineering of solvent-exposed loops in Escherichia coli \u03b2-galactosidase","volume":"434","author":"Feliu","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1006\/bbrc.2001.5157_RF10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0969-2126(00)00014-9","article-title":"The structure and antigenicity of a type C foot-and-mouth disease virus","volume":"2","author":"Lea","year":"1994","journal-title":"Structure"},{"key":"10.1006\/bbrc.2001.5157_RF11","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/j.1460-2075.1995.tb07158.x","article-title":"Structure of the major antigenic loop of foot-and-mouth disease virus complexed to a neutralizing antibody. Direct involvement of the Arg-Gly-Asp motif in the interaction","volume":"14","author":"Verdaguer","year":"1995","journal-title":"EMBO J."},{"key":"10.1006\/bbrc.2001.5157_RF12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-1119(96)00413-1","article-title":"A recombinant, arginine-glycine-aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and, to a lower extent, fibronectin receptors","volume":"180","author":"Villaverde","year":"1996","journal-title":"Gene"},{"key":"10.1006\/bbrc.2001.5157_RF13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1097-0290(19980805)59:3<294::AID-BIT5>3.0.CO;2-6","article-title":"A cell adhesion peptide from foot-and-mouth disease virus can direct cell targeted delivery of a functional enzyme","volume":"59","author":"Villaverde","year":"1998","journal-title":"Biotechnol. Bioeng."},{"key":"10.1006\/bbrc.2001.5157_RF14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1006\/bbrc.2000.3824","article-title":"Molecular organization of protein-DNA complexes for cell-targeted DNA delivery","volume":"278","author":"Ar\u0131&#x0301;s","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/bbrc.2001.5157_RF15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1099\/0022-1317-71-3-629","article-title":"A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C","volume":"71","author":"Mateu","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1006\/bbrc.2001.5157_RF16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/jmbi.1998.2104","article-title":"Conformational flexibility in a highly mobile protein loop of foot-and-mouth disease virus: Distinct structural requirements for integrin and antibody binding","volume":"283","author":"Feliu","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1006\/bbrc.2001.5157_RF17","first-page":"107","article-title":"Insertion of a 27 amino acid viral peptide in different zones of E. coli \u03b2-galactosidase: Effects on enzyme activity","volume":"123","author":"Benito","year":"1994","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1006\/bbrc.2001.5157_RF18","doi-asserted-by":"crossref","first-page":"12814","DOI":"10.1074\/jbc.271.22.12814","article-title":"Systematic replacement of amino acid residues within an Arg-Gly-Asp-containig loop of foot-and-mouth disease virus and effect on cell recognition","volume":"271","author":"Mateu","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1006\/bbrc.2001.5157_RF19","doi-asserted-by":"crossref","first-page":"21251","DOI":"10.1074\/jbc.271.35.21251","article-title":"\u03b2-Galactosidase enzymatic activity as a molecular probe to detect specific antibodies","volume":"271","author":"Benito","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1006\/bbrc.2001.5157_RF20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0014-5793(00)01582-9","article-title":"Successful mimicry of a complex viral antigen by multiple peptide insertions in a carrier protein","volume":"474","author":"Feliu","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1006\/bbrc.2001.5157_RF21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/1097-0290(20010205)72:3<255::AID-BIT1>3.0.CO;2-#","article-title":"Variable specific activity of Escherichia coli \u03b2-galactosidase in bacterial cells","volume":"72","author":"Cazorla","year":"2001","journal-title":"Biotechnol. Bioeng."},{"key":"10.1006\/bbrc.2001.5157_RF22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0378-1119(84)90162-8","article-title":"One-step purification of hybrid proteins which have \u03b2-galactosidase activity","volume":"29","author":"Ullmann","year":"1984","journal-title":"Gene"},{"key":"10.1006\/bbrc.2001.5157_RF23","unstructured":"Capucci, L., Brocchi, E., De Simone, F., and Panina, G. F.1984InReport of a Session of the Research Group of the Standing Thechnical Committee of the European Commission for the Control of Foot-and-Mouth Disease, pp 32\u201339, Brescia, Food and Agriculture Organization of the United Nations."},{"key":"10.1006\/bbrc.2001.5157_RF24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1128\/JVI.72.1.739-748.1998","article-title":"A similar pattern of interaction for different antibodies with a major antigenic site of foot-and. mouth disease virus: Implications for intratypic antigenic variation","volume":"72","author":"Verdaguer","year":"1998","journal-title":"J. Virol."},{"key":"10.1006\/bbrc.2001.5157_RF25","first-page":"418","article-title":"Microelisa reader quantitation of fixed, stained, solubilized cells in microtitre dishes","volume":"6","author":"Brasaemle","year":"1988","journal-title":"Biotechniques"},{"key":"10.1006\/bbrc.2001.5157_RF26","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1128\/JVI.69.4.2664-2666.1995","article-title":"Antibodies to the vitronectin receptor (integrin \u03b1v\u03b23) inhibit binding and infection of foot-and-mouth disease virus to cultured cells","volume":"69","author":"Berinstein","year":"1995","journal-title":"J. Virol."},{"key":"10.1006\/bbrc.2001.5157_RF27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"10.1006\/bbrc.2001.5157_RF28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0009-8981(73)90211-8","article-title":"Enzyme-linked immunoassay for alpha-fetoprotein by competitive and sandwich procedures","volume":"48","author":"Belanger","year":"1973","journal-title":"Clin. Chim. Acta."},{"key":"10.1006\/bbrc.2001.5157_RF29","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1128\/JVI.71.11.8357-8361.1997","article-title":"Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro","volume":"71","author":"Jackson","year":"1997","journal-title":"J. Virol."},{"key":"10.1006\/bbrc.2001.5157_RF30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0014-5793(98)01315-5","article-title":"Distinct mechanisms of antibody-mediated enzymatic reactivation in \u03b2-galactosidase molecular sensors","volume":"438","author":"Feliu","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1006\/bbrc.2001.5157_RF31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-5793(00)01481-2","article-title":"Distinct mechanisms of antibody-mediated enzymatic reactivation in \u03b2-galactosidase molecular sensors (Corrigendum)","volume":"473","author":"Feliu","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1006\/bbrc.2001.5157_RF32","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1006\/bbrc.2000.3309","article-title":"Molecular mechanisms for antibody-mediated modulation of peptide-displaying enzyme sensors","volume":"275","author":"Ferrer-Miralles","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/bbrc.2001.5157_RF33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1099\/0022-1317-81-5-1383","article-title":"Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin alpha5beta1: Influence of the leucine residue within the RGDL motif on selectivity of integrin binding","volume":"8","author":"Jackson","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1006\/bbrc.2001.5157_RF34","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1128\/JVI.70.6.4045-4052.1996","article-title":"Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions","volume":"70","author":"Chambers","year":"1996","journal-title":"J. Virol."},{"key":"10.1006\/bbrc.2001.5157_RF35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00102-6","article-title":"Gene delivery systems: Bridging the gap between recombinant viruses and artificial vectors","volume":"30","author":"Navarro","year":"1998","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1006\/bbrc.2001.5157_RF36","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1089\/hum.1998.9.7-1037","article-title":"An RGD-oligolysine peptide: A prototype construct for integrin-mediated gene delivery","volume":"9","author":"Harbottle","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1006\/bbrc.2001.5157_RF37","doi-asserted-by":"crossref","first-page":"19543","DOI":"10.1016\/S0021-9258(18)55029-8","article-title":"Arginine-glycine-aspartic acid binding leading to molecular stabilization between integrin alphavbeta3 and its ligand","volume":"266","author":"Orlando","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1006\/bbrc.2001.5157_RF38","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1073\/pnas.92.13.5783","article-title":"A molecular sensor system based on genetically alkaline phosphatase","volume":"92","author":"Brennan","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/bbrc.2001.5157_RF39","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/5243","article-title":"Engineering a regulatable enzyme for homogeneous immunoassays","volume":"17","author":"Legendre","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1006\/bbrc.2001.5157_RF40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0014-5793(99)00732-2","article-title":"Design of generic biosensors based on green fluorescent proteins with allosteric sites by directed evolution","volume":"453","author":"Doi","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1006\/bbrc.2001.5157_RF41","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1128\/JVI.72.5.3587-3594.1998","article-title":"Foot-and-mouth disease virus virulent for cattle utilises the integrin \u03b1v\u03b23 as its receptor","volume":"72","author":"Neff","year":"1998","journal-title":"J. Virol."},{"key":"10.1006\/bbrc.2001.5157_RF42","doi-asserted-by":"crossref","first-page":"7298","DOI":"10.1128\/JVI.74.16.7298-7306.2000","article-title":"High-efficiency utilization of the bovine integrin alpha(v)beta(3) as a receptor for foot-and-mouth disease virus is dependent on the bovine beta(3) subunit","volume":"74","author":"Neff","year":"2000","journal-title":"J. Virol."},{"key":"10.1006\/bbrc.2001.5157_RF43","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1128\/JVI.74.11.4949-4956.2000","article-title":"The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus","volume":"74","author":"Jackson","year":"2000","journal-title":"J. Virol."},{"key":"10.1006\/bbrc.2001.5157_RF44","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1128\/JVI.68.9.5925-5932.1994","article-title":"Vitronectin receptor antibodies inhibit infection of HeLa and A549 cells by adenovirus type 12 but not by adenovirus type 2","volume":"68","author":"Bai","year":"1994","journal-title":"J. Virol."},{"key":"10.1006\/bbrc.2001.5157_RF45","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1006\/viro.1999.0010","article-title":"Integrin alphaVbeta5 is not involved in adeno-associated virus type 2 (AAV2) infection","volume":"264","author":"Qiu","year":"1999","journal-title":"Virology"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X01951575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X01951575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T02:54:23Z","timestamp":1620010463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X01951575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["S0006291X01951575"],"URL":"https:\/\/doi.org\/10.1006\/bbrc.2001.5157","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}